Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2019, Article ID 8727935, 7 pages
https://doi.org/10.1155/2019/8727935
Research Article

Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis

Wenjing Wang,1,2,3 Shubin Niu,4 Luxin Qiao,1,2,3 Feili Wei,1,2,3 Jiming Yin,1,2,3 Shanshan Wang,1,2,3 Yabo Ouyang,1,2,3 and Dexi Chen1,2,3

1Capital Medical University Affiliated Beijing You An Hospital, Beijing, 100069, China
2Beijing Institute of Hepatology, Beijing, 100069, China
3Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer, 100069, China
4School of biomedicine, Beijing City University, No. 6 Huanghoudian Road Haidian District, Beijing, 100094, China

Correspondence should be addressed to Dexi Chen; nc.ude.umcc@nehcixed

Received 10 September 2018; Revised 8 December 2018; Accepted 23 December 2018; Published 11 February 2019

Academic Editor: Adair Santos

Copyright © 2019 Wenjing Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Wenjing Wang, Shubin Niu, Luxin Qiao, et al., “Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis,” BioMed Research International, vol. 2019, Article ID 8727935, 7 pages, 2019. https://doi.org/10.1155/2019/8727935.